Obstructive sleep apnea happens when a person's upper airway becomes blocked and pauses breathing during sleep. The condition happens more often in people who are overweight or have obesity.

The worst of her sleep apnea symptoms have vanished. More Americans with obstructive sleep apnea, the most common form of the disorder, may soon turn to weight-loss drugs.

Obstructive sleep apnea (OSA) occurs when the upper airway collapses during sleep, reducing or completely blocking airflow. It’s primarily caused by a combination of impaired throat anatomy and ...

While people are more at risk for obstructive sleep apnea as they get older, it often develops when people gain weight and have overweight or obesity. Fat deposits around the upper airway will end ...

Obstructive sleep apnea is more common in men than women. Up to 34% of U.S. men have OSA compared to 17% of U.S. women, according to the American Academy of Family Physicians.

Zepbound’s biggest competitor, Novo Nordisk’s weight loss drug Wegovy, has also been forecast to reduce the prevalence of obstructive sleep apnea 10.7% by 2030.

The FDA approved a new drug called Zepbound, which activates GLP-1 to help with obstructive sleep apnea, while also resulting in weight loss.

The primary treatment for people with moderate (15 to 29 AHI) or severe (30 AHI and higher) obstructive sleep apnea is a continuous positive airway pressure (CPAP) machine, which keeps your airway ...

A sleep specialist and an endocrinologist discuss ways to engage patients in difficult conversations and shared decision-making to better manage the related conditions of sleep apnea and obesity.

With the global sleep apnea device market valued at $8.52 billion in 2024 and projected to rise to nearly $13 billion by 2030, according to one 2025 report, medical tech companies are developing ...

Health Nation Nation & World FDA approves weight-loss drug to treat obstructive sleep apnea Dec. 20, 2024 at 3:24 pm Updated Dec. 20, 2024 at 4:24 pm By Dani Blum ...

Sleep apnea’s effects extend far beyond increasing the risk of Parkinson’s disease. Untreated OSA has been linked to numerous serious health conditions that affect both quality and length of life.